Treatment of HeLa cells with a DNA topoisomerase I-specific inhibitor, camptothecin, results in rapid cessation of the synthesis of the 45S rRNA precursor. The inhibition of rRNA synthesis is reversible following drug removal and correlates with the presence of camptothecintrapped topoisomerase I-DNA abortive complexes, which can be detected as topoisomerase I-linked DNA breaks upon lysis with sodium dodecyl sulfate. These breaks were found to be concentrated within the transcribed region of human rRNA genes. No such sites can be detected in the inactive human rRNA genes in mouse-human hybrid cells, suggesting a preferential association of topoisomerase I with actively transcribed genes. The distribution of RNA polymerase molecules along the transcription unit of human rRNA genes in camptothecin-treated HeLa cells, as assayed by nuclear run-on transcription, shows a graded decrease of the RNA polymerase density toward the 3' end of the transcription unit; the density is minimally affected near the 5' start of the transcription unit. These results suggest that DNA topoisomerase I is normally involved in the elongation step of transcription, especially when the transcripts are long, and that camptothecin interferes with this role.
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Transcription of DNA requires the rotation of RNA polymerase and its associated components around the DNA or the rotation of DNA around its helical axis. It has been suggested that the process might be facilitated by the introduction of a "swivel" into the DNA, which would allow the rotation of segments of DNA being transcribed without turning the other parts of DNA or the transcription ensembles (1) (2) (3) (4) . The evidence now indicates that eukaryotic DNA topoisomerase I is preferentially associated with actively transcribed regions on chromatin (5) . Immunological and UV-crosslinking studies have shown that following heat shock, there is an enrichment of topoisomerase I within the transcribed regions of the heat shock loci of Drosophila chromosomes (6, 7) . Immunofluorescence studies have shown that nucleoli, in which rRNA genes are being transcribed at a high rate, are highly enriched in topoisomerase I (6, 8) . Consistent with these data, isolated nucleoli have also been shown to contain a high level of topoisomerase I activity (8, 9) . Further, it was found that topoisomerase I-mediated nicking of DNA occurred upstream of the promoter of rRNA genes in Tetrahymena macronuclei, in the same region as the DNase I-hypersensitive sites (10) . Using mutants defective in one or both topoisomerases, it was demonstrated that the synthesis of rRNA in the distantly related yeasts Schizosaccharomyces pombe and Saccharomyces cerevisiae was most severely inhibited when both topoisomerase activities were absent; there was little effect on rRNA synthesis in either top] or top2 single mutants.
These results suggest that a topoisomerase activity is required for rRNA transcription and that either topoisomerase I or topoisomerase II is sufficient for such a requirement (11, 12) .
Recently, several specific inhibitors for mammalian DNA topoisomerases have been identified and characterized (13, 14) . For example, camptothecin and VM-26 (teniposide) specifically inhibit mammalian DNA topoisomerases I and II, respectively, by trapping an abortive enzyme-DNA complex termed the cleavable complex. Treatment of these complexes with protein denaturant leads to DNA strand breaks and the concomitant linking of a topoisomerase polypeptide to the 3' end (in the case of topoisomerase I) or the 5' end (in the case of topoisomerase II) of the broken DNA strands. These inhibitors may thus be used to study both the functional involvement of topoisomerase activities and the chromosomal locations of topoisomerases.
In this communication, we report studies on the involvement of topoisomerase I in the transcription of human rRNA genes by RNA polymerase I, using the topoisomerase Ispecific inhibitor camptothecin. Our results indicate that DNA topoisomerase I is enriched within the transcribed region of human rRNA genes and its presence correlates with the transcriptional state of the genes. A similar conclusion was drawn recently by Gilmour and Elgin (15) and by Stewart and Schutz (16) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. lated from the lysates by phenol extraction and ethanol precipitation. Isolated DNA was digested with restriction enzymes and analyzed by electrophoresis in either nondenaturing or formamide-containing denaturing agarose gel (17) . DNA was blotted onto GeneScreen membrane filters and hybridized with various human rRNA gene probes that had been 32P-labeled by the hexanucleotide random-priming method (18) .
Isolation of Protein-Linked DNA. HeLa cells were treated with either 60 AtM camptothecin from a 20 mM stock solution (in Me2SO) or the same amount of Me2SO (final concentration, 1%) for 15 min and then lysed with the NaDodSO4/ EDTA buffer. The lysates were passed through a 20-gauge needle to shear DNA into small pieces and then extracted three times with an equal volume of phenol. After centrifugation to separate the proteinaceous interface from the aqueous supernatant, the supernatant was carefully pipeted into a clean tube. The proteinaceous material in the interface was also collected. DNA in the interface and supernatant was then precipitated with ethanol, digested with proteinase K, and processed as described above. Nuclear Run-On Transcription. Nuclear run-on assays were done according to Greenberg and Ziff (19) tandem repeats in four different chromosomal loci (20) . Each repeat is composed of a 31-kilobase (kb) spacer and a 13-kb transcribed region, which codes for the 45S rRNA precursor. The transcribed region contains the 18S, 5.8S, and 28S genes (Fig. 1) .
In order to locate topoisomerase I on human rRNA genes, HeLa genes were treated with camptothecin and immediately lysed with a buffer containing NaDodSO4 to induce topoisomerase I-linked DNA breaks; these breaks were then located by the indirect end-labeling method (15, 16, 21) , using cloned rRNA gene fragments RSB and Abe shown in Fig. 1 (Fig. 2) was used for indirect end-labeling.
Prominent double-strand DNA breaks were observed in these experiments. Double-strand as well as single-strand DNA breaks were observed previously (15, 16, 21) . In the present experiments, double-strand breaks were observed at the sites indicated by numbered arrows in Fig. 1 , primarily within the transcribed region; no breaks were detected in the nontranscribed spacer region. These double-strand breaks appear within minutes following camptothecin addition to the culture medium and also disappear rapidly upon drug removal (data not shown). associated with covalently bound protein (topoisomerase I), repeated phenol extractions of cell lysates showed that DNA containing such breaks was enriched in the proteinaceous material at the phenol/water interface (Fig. 2) .
Using purified calf thymus DNA topoisomerase I, we also mapped cleavage sites on a cloned human rRNA gene fragment in vitro. As shown in Fig. 3 , the addition of camptothecin to the reaction mixture induced double-strand DNA breaks at sites similar to those observed in vivo. In the absence of camptothecin and at higher concentrations of purified topoisomerase I, cleavage at similar places was observed (Fig. 3, lanes 2) . These results again support the notion that the in vivo cleavage sites induced by camptothecin were topoisomerase I-mediated.
Preferential Association of Topoisomerase I with Actively Transcribed Human rRNA Genes. To test whether the presence of camptothecin-induced, topoisomerase I-linked DNA breaks correlates with the transcriptional state of human rRNA genes, we examined camptothecin-induced DNA breaks in two different mouse-human hybrid cell lines, MH1 and MH2. Although both human and mouse rRNA genes are present in the hybrid cells, only the mouse genes are active, presumably due to the lack of species-specific initiation factor(s) for the human rRNA genes (22) . DNA breaks induced by camptothecin in the various cell lines were mapped by use of appropriate cloned probes (Fig. 4) . Whereas topoisomerase I-linked DNA breaks were detected in the rRNA genes in HeLa cells, they were not observed in the human rRNA genes in the hybrid cells, suggesting that topoisomerase I is preferentially associated with actively transcribed rRNA genes. Control experiments using mouse rRNA gene probes showed that topoisomerase I-linked DNA breaks mapped within the transcribed unit of mouse rRNA genes in both mouse 3T3 cells and hybrid cells (data not shown).
Distance-Dependent Inhibition of Nuclear Run-On rRNA Transcription by Camptothecin. Treatment of HeLa cells with camptothecin results in rapid inhibition of [3H] uridine incorporation and severe inhibition of the 45S rRNA precursor synthesis (data not shown). To test whether camptothecin inhibits initiation or elongation of RNA transcription, the nuclear run-on assay (19) was used to monitor the distribution of RNA polymerase molecules within the transcription unit of human rRNA genes. In this assay, nuclear transcripts that had been initiated prior to the isolation of nuclei were labeled by the addition of a-32P-labeled triphosphates to the nuclei. Samples of the labeled RNA were hybridized to various cloned rRNA gene fragments immobilized on membrane filters (Fig. 5a ). The treatment of HeLa cells with camptothecin causes a graded reduction of nuclear run-on transcripts along the transcription unit: transcripts near the immediate 5' end of the transcription unit are minimally affected, whereas transcripts near the 3' end of the transcription unit are almost completely abolished. The intensities of these bands were quantitated by densitometry (Fig. Sb) . The graded decrease of the nuclear run-on transcripts toward the 3' end of the transcription unit signifies a parallel decrease of the RNA polymerase density toward the 3' end of the transcription unit. There is a slight stimulation of nuclear run-on transcription near the immediate 5' end of the gene (Fig. 5b) . This stimulation becomes more pronounced when rRNA transcription slows down (e.g., in confluent HeLa cells or confluent NIH 3T3 cells) (data not shown).
DISCUSSION
Using camptothecin to trap covalent complexes between DNA and topoisomerase I, we found that the enzyme is present within the transcribed region of rRNA genes in HeLa cells but is absent in the nontranscribed spacer region in the same cells or in inactive human rRNA genes in mouse-human hybrid cells. These results, together with previous findings (5-12, 15, 16) , suggest that DNA topoisomerase I is functionally associated with genes being actively transcribed by either RNA polymerase I or RNA polymerase II.
Camptothecin is a reversible inhibitor of RNA synthesis in mammalian cells and is known to inhibit the synthesis of high molecular weight RNAs such as the 45S rRNA precursor and heterogeneous nuclear RNAs (23, 24) . Inhibition of rat rRNA synthesis in a partially purified system by the drug was reported recently (25) . Experiments on the effect of camptothecin on nuclear run-on rRNA transcription were carried out. Whereas the amounts of nuclear run-on tran- 
